D-0013-2027 Class II Ongoing
FDA drug recall D-0013-2027 was initiated by Preferred Pharmaceuticals, Inc. on Sep 28, 2026 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 14, 2026
- Initiation Date
- Sep 28, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Reason for Recall
Failed Content Uniformity Specifications
Distribution Pattern
USA Nationwide
Code Information
Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0013-2027
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026